Resumen

NARVAEZ, Nicole Salomé Figueroa  y  JERVES, Jorge Andrés Torres. Fecal microbiota transplantation as a treatment alternative for clostridoides difficile infections. Vive Rev. Salud [online]. 2023, vol.6, n.16, pp.66-77.  Epub 14-Feb-2023. ISSN 2664-3243.  https://doi.org/10.33996/revistavive.v6i16.207.

Clostridioides difficile infection is a public health threat, is associated with health care, the most common complication of which is recurrent infection, with rates of up to 60% after the third episode. Treatment options for recurrence of this infection are limited. A great paradox is to treat an antibiotic-associated infection with more antibiotics; therefore, the cornerstone in the management of this infection is the restoration of the intestinal microbiota by fecal microbiota transplantation. Objective. To determine the efficacy and safety of fecal microbiota transplantation for the treatment of recurrent Clostridioides difficile infection. Methodology. A narrative bibliographic review of the scientific literature was carried out in the PubMed and Cochrane Library databases using the Health Sciences Descriptors (DeCS) and Medical Subject Headings (MeSH), together with the Boolean operators "AND/Y", "OR/O"; where the studies that met the inclusion criteria were collected. Conclusion. It was concluded that fecal microbiota transplantation in recurrent Clostridioides difficile infection is an effective and safe treatment, with minimal adverse events, although long-term safety is not well established.

Palabras clave : Clostridium difficile; Efficacy; Safety; Fecal Microbiota Transplantation.

        · resumen en Español | Portugués     · texto en Español     · Español ( pdf )